Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block

Debra L. Davey, Susan L. Bratton, David J. Bradley, Anji T. Yetman

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

An association between congenital complete atrioventricular block (cCAVB) and aortic dilation during childhood has recently been reported. We sought to further explore this relation with particular emphasis on the natural history of aortic abnormalities over time. The relation of maternal anti-Ro/La antibody status to the aortic size of children affected with cCAVB was also assessed. The patients were evaluated longitudinally with serial echocardiography. During a 15-year period, 62 patients at our institution were diagnosed with cCAVB, of whom 40% were exposed to maternal autoimmune antibodies and 35% were not. The antibody status in the remaining patients was unknown. The patients underwent 9.3 ± 6.5 echocardiograms during the follow-up period. Dilation of the ascending aorta, defined as a z score >2.0, was present on the initial echocardiogram in all patients exposed to maternal antibodies and persisted during long-term follow-up in 96% of these patients. In contrast, 5% and 10% of patients without exposure to maternal autoimmune antibodies had aortic dilation on the initial and follow-up studies, respectively (p <0.001 and p <0.001, respectively). In conclusion, patients with autoimmune-mediated cCAVB merit periodic echocardiographic monitoring into adulthood to assess persistent or progressive aortic dilation and its attendant complications.

Original languageEnglish (US)
Pages (from-to)561-564
Number of pages4
JournalAmerican Journal of Cardiology
Volume108
Issue number4
DOIs
StatePublished - Aug 15 2011
Externally publishedYes

Fingerprint

Dilatation
Mothers
Atrioventricular Block
Antibodies
Maternal Exposure
SS-A antibodies
Congenital heart block
Natural History
Echocardiography
Aorta

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block. / Davey, Debra L.; Bratton, Susan L.; Bradley, David J.; Yetman, Anji T.

In: American Journal of Cardiology, Vol. 108, No. 4, 15.08.2011, p. 561-564.

Research output: Contribution to journalArticle

@article{08dc1eb72ebf404ea863720ef1b58015,
title = "Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block",
abstract = "An association between congenital complete atrioventricular block (cCAVB) and aortic dilation during childhood has recently been reported. We sought to further explore this relation with particular emphasis on the natural history of aortic abnormalities over time. The relation of maternal anti-Ro/La antibody status to the aortic size of children affected with cCAVB was also assessed. The patients were evaluated longitudinally with serial echocardiography. During a 15-year period, 62 patients at our institution were diagnosed with cCAVB, of whom 40{\%} were exposed to maternal autoimmune antibodies and 35{\%} were not. The antibody status in the remaining patients was unknown. The patients underwent 9.3 ± 6.5 echocardiograms during the follow-up period. Dilation of the ascending aorta, defined as a z score >2.0, was present on the initial echocardiogram in all patients exposed to maternal antibodies and persisted during long-term follow-up in 96{\%} of these patients. In contrast, 5{\%} and 10{\%} of patients without exposure to maternal autoimmune antibodies had aortic dilation on the initial and follow-up studies, respectively (p <0.001 and p <0.001, respectively). In conclusion, patients with autoimmune-mediated cCAVB merit periodic echocardiographic monitoring into adulthood to assess persistent or progressive aortic dilation and its attendant complications.",
author = "Davey, {Debra L.} and Bratton, {Susan L.} and Bradley, {David J.} and Yetman, {Anji T.}",
year = "2011",
month = "8",
day = "15",
doi = "10.1016/j.amjcard.2011.03.090",
language = "English (US)",
volume = "108",
pages = "561--564",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Relation of maternal anti-Ro/La antibodies to aortic dilation in patients with congenital complete heart block

AU - Davey, Debra L.

AU - Bratton, Susan L.

AU - Bradley, David J.

AU - Yetman, Anji T.

PY - 2011/8/15

Y1 - 2011/8/15

N2 - An association between congenital complete atrioventricular block (cCAVB) and aortic dilation during childhood has recently been reported. We sought to further explore this relation with particular emphasis on the natural history of aortic abnormalities over time. The relation of maternal anti-Ro/La antibody status to the aortic size of children affected with cCAVB was also assessed. The patients were evaluated longitudinally with serial echocardiography. During a 15-year period, 62 patients at our institution were diagnosed with cCAVB, of whom 40% were exposed to maternal autoimmune antibodies and 35% were not. The antibody status in the remaining patients was unknown. The patients underwent 9.3 ± 6.5 echocardiograms during the follow-up period. Dilation of the ascending aorta, defined as a z score >2.0, was present on the initial echocardiogram in all patients exposed to maternal antibodies and persisted during long-term follow-up in 96% of these patients. In contrast, 5% and 10% of patients without exposure to maternal autoimmune antibodies had aortic dilation on the initial and follow-up studies, respectively (p <0.001 and p <0.001, respectively). In conclusion, patients with autoimmune-mediated cCAVB merit periodic echocardiographic monitoring into adulthood to assess persistent or progressive aortic dilation and its attendant complications.

AB - An association between congenital complete atrioventricular block (cCAVB) and aortic dilation during childhood has recently been reported. We sought to further explore this relation with particular emphasis on the natural history of aortic abnormalities over time. The relation of maternal anti-Ro/La antibody status to the aortic size of children affected with cCAVB was also assessed. The patients were evaluated longitudinally with serial echocardiography. During a 15-year period, 62 patients at our institution were diagnosed with cCAVB, of whom 40% were exposed to maternal autoimmune antibodies and 35% were not. The antibody status in the remaining patients was unknown. The patients underwent 9.3 ± 6.5 echocardiograms during the follow-up period. Dilation of the ascending aorta, defined as a z score >2.0, was present on the initial echocardiogram in all patients exposed to maternal antibodies and persisted during long-term follow-up in 96% of these patients. In contrast, 5% and 10% of patients without exposure to maternal autoimmune antibodies had aortic dilation on the initial and follow-up studies, respectively (p <0.001 and p <0.001, respectively). In conclusion, patients with autoimmune-mediated cCAVB merit periodic echocardiographic monitoring into adulthood to assess persistent or progressive aortic dilation and its attendant complications.

UR - http://www.scopus.com/inward/record.url?scp=79960916472&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960916472&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2011.03.090

DO - 10.1016/j.amjcard.2011.03.090

M3 - Article

C2 - 21624539

AN - SCOPUS:79960916472

VL - 108

SP - 561

EP - 564

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 4

ER -